Hospital Melaka Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01091701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Hospital Melaka Consultant Neurologist, Neurology Clinic, Medical Department, Jalan Mufti Haji Khalil, 75400 Melaka

Active Ingredients

Drugs in Phase 2 Trials (1)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1